← All organizations

Intellia Therapeutics

For profit

Also known as: Intellia Therapeutics

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Nov 30, 2024

Timeline

2010s

Jun 1, 2014
Intellia Therapeutics— Founded

Drugs by trial phase (6 distinct, 8 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (4 own, 0 via acquisition)

Indications

Studied for

Recent trials (8)

NCT06672237Lead sponsorPhase 3Nov 30, 2024
NCT06634420Lead sponsorPhase 3Oct 31, 2024
NCT06622668Lead sponsorPhase 1/Phase 2Oct 31, 2024
NCT06379789CollaboratorPhase 1/Phase 2Sep 11, 2024
NCT06128629Lead sponsorPhase 3Dec 31, 2023
NCT05066165Lead sponsorPhase 1/Phase 2Nov 22, 2021
NCT05120830Lead sponsorPhase 1/Phase 2Nov 15, 2021
NCT04601051Lead sponsorPhase 1Nov 5, 2020

Details

Founded: Cambridge, MA, US Jun 1, 2014
Last known activity: Nov 30, 2024